journal article·2023-08-22Open access

Multifunctional Calcium–Manganese Nanomodulator Provides Antitumor Treatment and Improved Immunotherapy via Reprogramming of the Tumor Microenvironment

Guanghong Luo, Xing Li, Jihui Lin, Gao Ge, Jiangli Fang, Wangze Song, Gary Guishan Xiao, Bo Zhang, Xiaojun Peng, Yanhong Duo, Ben Zhong Tang

ACS Nano· Volume 17· Issue 16

Abstract

High Resolution Image Download MS PowerPoint Slide Ions play a vital role in regulating various biological processes, including metabolic and immune homeostasis, which involves tumorigenesis and therapy. Thus, the perturbation of ion homeostasis can induce tumor cell death and evoke immune responses, providing specific antitumor effects. However, antitumor strategies that exploit the effects of multiion perturbation are rare. We herein prepared a pH-responsive nanomodulator by coloading curcumin (CU, a Ca 2+ enhancer) with CaCO 3 and MnO 2 into nanoparticles coated with a cancer cell membrane. This nanoplatform was aimed at reprogramming the tumor microenvironment (TME) and providing an antitumor treatment through ion fluctuation. The obtained nanoplatform, called CM NPs, could neutralize protons by decomposing CaCO 3 and attenuating cellular acidity, they could generate Ca 2+ and release CU, elevating Ca 2+ levels and promoting ROS generation in the mitochondria and endoplasmic reticulum, thus, inducing immunogenic cell death. Mn 2+ could decompose the endogenous H 2 O 2 into O 2 to relieve hypoxia and enhance the sensitivity of cGAS, activating the cGAS-STING signaling pathway. In addition, this strategy allowed the reprogramming of the immune TME, inducing macrophage polarization and dendritic cell maturation via antigen cross-presentation, thereby increasing the immune system’s ability to combat the tumor effectively. Moreover, the as-prepared nanoparticles enhanced the antitumor responses of the αPD1 treatment. This study proposes an effective strategy to combat tumors via the reprogramming of the tumor TME and the alteration of essential ions concentrations. Thus, it shows great potential for future clinical applications as a complementary approach along with other multimodal treatment strategies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Medicine, The 2nd Affiliated Hospital, The Chinese University of Hong Kong, Shenzhen (CUHK-Shenzhen), Guangdong 518172, P.R. China

Department of Radiation Oncology, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, Guangdong China

School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China

School of Nursing, Southwest Medical University, Luzhou, Sichuan 646000, China

Department of Laboratory Medicine, The Third Xiangya Hospital, Central South University, Changsha, 410013, China

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, 171 77, Sweden

State Key Laboratory of Fine Chemicals, Department of Pharmacology, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China

Research Center for Cancer Metabolism, College of Pharmacology, Shenzhen University of Technology, Chinese Academy of Sciences, Shenzhen, 518118, China

Department of Neurosurgery, The Shenzhen Luohu Hospital Group, The Third Affiliated Hospital of Shenzhen University, Shenzhen 518001, China

State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China

Key Lab for New Drug Research of TCM, Research Institute of Tsinghua University in Shenzhen, Shenzhen 518057, Guangdong China

Shenzhen Institute of Aggregate Science and Technology, School of Science and Engineering, The Chinese University of Hong Kong, Shenzhen. Shenzhen 518172, Guangdong China

Funding

Science, Technology and Innovation Commission of Shenzhen Municipality · National Natural Science Foundation of China · Natural Science Foundation of Guangdong Province

References (81)

Show source-provided references
1. 10.1016/j.jncc.2022.02.00210.1016/j.jncc.2022.02.002 ↗
2. 10.1038/nrc323910.1038/nrc3239 ↗
3. 10.1038/nrc.2016.3610.1038/nrc.2016.36 ↗
4. 10.1056/NEJMra170348110.1056/NEJMra1703481 ↗
5. 10.1056/NEJMoa120069010.1056/NEJMoa1200690 ↗
6. 10.1016/j.cell.2019.10.02910.1016/j.cell.2019.10.029 ↗
7. 10.1158/2159-8290.CD-20-180810.1158/2159-8290.CD-20-1808 ↗
8. 10.1038/nm.339410.1038/nm.3394 ↗
9. 10.1016/j.molcel.2020.05.03410.1016/j.molcel.2020.05.034 ↗
10. 10.1038/s41568-021-00378-610.1038/s41568-021-00378-6 ↗
11. 10.1038/s41467-021-27750-210.1038/s41467-021-27750-2 ↗
12. 10.1016/j.molcel.2018.08.01410.1016/j.molcel.2018.08.014 ↗
13. 10.1073/pnas.210352611810.1073/pnas.2103526118 ↗
14. 10.15252/embr.20205116210.15252/embr.202051162 ↗
15. 10.1038/s41580-020-00324-810.1038/s41580-020-00324-8 ↗
16. 10.1016/j.chempr.2019.06.00310.1016/j.chempr.2019.06.003 ↗
17. 10.1021/acsnano.1c0789310.1021/acsnano.1c07893 ↗
18. 10.1146/annurev-immunol-032414-11221210.1146/annurev-immunol-032414-112212 ↗
19. 10.2741/466510.2741/4665 ↗
20. 10.1002/EXP.2021015710.1002/EXP.20210157 ↗
21. 10.1007/s12274-020-3243-510.1007/s12274-020-3243-5 ↗
22. 10.1016/j.bioactmat.2022.06.00510.1016/j.bioactmat.2022.06.005 ↗
23. 10.1021/acsnano.8b0938710.1021/acsnano.8b09387 ↗
24. 10.1002/VIW.2023000110.1002/VIW.20230001 ↗
25. 10.1038/nrm115010.1038/nrm1150 ↗
26. 10.1016/j.ijbiomac.2021.10.01410.1016/j.ijbiomac.2021.10.014 ↗
27. 10.1038/nature1169910.1038/nature11699 ↗
28. 10.1021/acsnano.0c0388110.1021/acsnano.0c03881 ↗
29. 10.1038/s41551-023-01014-410.1038/s41551-023-01014-4 ↗
30. 10.1021/acs.nanolett.0c0477810.1021/acs.nanolett.0c04778 ↗
31. 10.3390/biomedicines909107710.3390/biomedicines9091077 ↗
32. 10.1002/anie.20210270310.1002/anie.202102703 ↗
33. 10.1016/j.immuni.2018.03.01710.1016/j.immuni.2018.03.017 ↗
34. 10.1038/s41422-020-00395-410.1038/s41422-020-00395-4 ↗
35. 10.1016/bs.ai.2019.11.00710.1016/bs.ai.2019.11.007 ↗
36. 10.1038/s41423-021-00669-w10.1038/s41423-021-00669-w ↗
37. 10.1038/s41565-021-00962-910.1038/s41565-021-00962-9 ↗
38. 10.1021/acsnano.6b0120610.1021/acsnano.6b01206 ↗
39. 10.7150/thno.5334610.7150/thno.53346 ↗
40. 10.1021/jacs.2c0766910.1021/jacs.2c07669 ↗
41. 10.1126/science.aaw547310.1126/science.aaw5473 ↗
42. 10.1021/acsnano.0c0388110.1021/acsnano.0c03881 ↗
43. 10.1002/adma.20200742610.1002/adma.202007426 ↗
44. 10.1021/acsnano.8b0203410.1021/acsnano.8b02034 ↗
45. 10.1016/j.foodchem.2021.12915710.1016/j.foodchem.2021.129157 ↗
46. 10.1016/j.biomaterials.2017.04.01810.1016/j.biomaterials.2017.04.018 ↗
47. 10.1093/neuonc/nov15110.1093/neuonc/nov151 ↗
48. 10.1021/acsami.1c0043010.1021/acsami.1c00430 ↗
49. 10.1093/jnci/djy13110.1093/jnci/djy131 ↗
50. 10.1002/adma.20210652010.1002/adma.202106520 ↗
51. 10.1016/j.chempr.2020.02.02010.1016/j.chempr.2020.02.020 ↗
52. 10.1016/j.ejphar.2020.17309010.1016/j.ejphar.2020.173090 ↗
53. 10.1016/j.biomaterials.2017.04.01810.1016/j.biomaterials.2017.04.018 ↗
54. 10.1021/acsami.0c0701310.1021/acsami.0c07013 ↗
55. 10.1021/acsnano.0c0629010.1021/acsnano.0c06290 ↗
56. 10.1016/j.talanta.2023.12447310.1016/j.talanta.2023.124473 ↗
57. 10.1039/D2QI00951J10.1039/D2QI00951J ↗
58. 10.1021/acsnano.1c0868910.1021/acsnano.1c08689 ↗
59. 10.1038/s42255-022-00730-610.1038/s42255-022-00730-6 ↗
60. 10.1146/annurev-physiol-021119-03462710.1146/annurev-physiol-021119-034627 ↗
61. 10.1038/nature1349010.1038/nature13490 ↗
62. 10.1038/nrm282010.1038/nrm2820 ↗
63. 10.1038/onc.2017.16710.1038/onc.2017.167 ↗
64. 10.1038/cdd.2011.13910.1038/cdd.2011.139 ↗
65. 10.1016/j.bbrc.2015.02.00410.1016/j.bbrc.2015.02.004 ↗
66. 10.7150/jca.1764810.7150/jca.17648 ↗
67. 10.1007/s40820-019-0347-010.1007/s40820-019-0347-0 ↗
68. 10.1002/adma.20210484910.1002/adma.202104849 ↗
69. 10.7150/thno.3758610.7150/thno.37586 ↗
70. 10.1002/adma.20190491410.1002/adma.201904914 ↗
71. 10.1002/adma.20200806510.1002/adma.202008065 ↗
72. 10.1021/acs.nanolett.9b0521010.1021/acs.nanolett.9b05210 ↗
73. 10.1038/s41423-021-00669-w10.1038/s41423-021-00669-w ↗
74. 10.3390/ijms2019496610.3390/ijms20194966 ↗
75. 10.1016/j.biomaterials.2018.03.00710.1016/j.biomaterials.2018.03.007 ↗
76. 10.1016/j.apsb.2021.12.01010.1016/j.apsb.2021.12.010 ↗
77. 10.1038/s41467-017-01050-010.1038/s41467-017-01050-0 ↗
78. 10.1021/acsbiomaterials.5b0018110.1021/acsbiomaterials.5b00181 ↗
79. 10.1016/j.bioactmat.2021.12.02910.1016/j.bioactmat.2021.12.029 ↗
80. 10.1073/pnas.101328510810.1073/pnas.1013285108 ↗
81. 10.1038/s41577-018-0110-710.1038/s41577-018-0110-7 ↗